Adma Biologics (ADMA) Profit After Tax (2011 - 2025)
Adma Biologics (ADMA) posted Profit After Tax of $49.4 million for Q4 2025, up 35.55% on a QoQ basis from $36.4 million in Q3 2025, and down 55.87% year-over-year from $111.9 million in Q4 2024.
Adma Biologics (ADMA) Profit After Tax (2011 - 2025) Analysis & Trends
Adma Biologics' Profit After Tax history runs 13 years deep, the most recent figure standing at $49.4 million for Q4 2025.
- Quarterly Profit After Tax fell 55.87% year-over-year to $49.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $146.9 million (down 25.67% YoY) and the FY2025 annual result came in at $146.9 million, down 25.67% from the prior year.
- Profit After Tax was $49.4 million for Q4 2025 at Adma Biologics, up from $36.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $111.9 million in Q4 2024 and bottomed at -$25.0 million in Q1 2022.
- A 5-year average of $8.9 million and a median of -$6.6 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 1299.96% — and 2025, when it plunged 55.87%.
- Adma Biologics' Profit After Tax stood at -$16.6 million in 2021, then increased by 26.54% to -$12.2 million in 2022, then slumped by 44.26% to -$17.6 million in 2023, then soared by 734.15% to $111.9 million in 2024, then plunged by 55.87% to $49.4 million in 2025.
- Business Quant data shows ADMA's Profit After Tax at $49.4 million in Q4 2025, $36.4 million in Q3 2025, and $34.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 49.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.38 Mn |
| Sep 30, 2025 | 36.43 Mn |
| Jun 30, 2025 | 34.22 Mn |
| Mar 31, 2025 | 26.90 Mn |
| Dec 31, 2024 | 111.90 Mn |
| Sep 30, 2024 | 35.91 Mn |
| Jun 30, 2024 | 32.06 Mn |
| Mar 31, 2024 | 17.81 Mn |
| Dec 31, 2023 | -17.65 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | -6.37 Mn |
| Mar 31, 2023 | -6.79 Mn |
| Dec 31, 2022 | -12.23 Mn |
| Sep 30, 2022 | -14.90 Mn |
| Jun 30, 2022 | -13.76 Mn |
| Mar 31, 2022 | -25.01 Mn |
| Dec 31, 2021 | -16.65 Mn |
| Sep 30, 2021 | -17.71 Mn |
| Jun 30, 2021 | -18.91 Mn |
| Mar 31, 2021 | -18.38 Mn |